NICE to rethink osteoporosis guidelines

Osteoporosis campaigners have won an appeal against NICE draft guidelines on treatment options for the condition.

The outcome has raised hopes that a greater range of treatments for the prevention of primary and secondary osteoporotic fractures could be recommended for use on the NHS.

Charities including the National Osteoporosis Society (NOS), the British Society for Rheumatology, the Society for Endocrinology and the Bone Research Society called for a rethink after a final appraisal determination issued in June featured only alendronate as a treatment for osteoporosis.

As one in four people are unable to tolerate the drug, the charities were concerned that without alternatives, some osteoporosis patients may miss out on treatment.

Chief executive of the NOS Claire Severginini said: ‘I am extremely pleased the appeal committee has listened.

‘NICE should not have changed the original scope of the guidance without full and proper consultation and this outcome is a real success for the charity.’

NICE said its intention in the draft guideline was to make it easier for at-risk women to access osteoporotic drugs.

Professor Peter Littlejohns, NICE clinical and public health director, said: ‘The appeal panel decided we did not go about this in the right way.

‘The appraisal committee therefore will reconsider all of the drugs which were part of the appraisal to produce guidance on treatment options for patients in whom alendronate is contraindicated, poorly tolerated or ineffective.’

rachel.liddle@haymarket.com

Comment below and tell us what you think 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

A 'tsunami' of work is drowning general practice: GPs speak out about a profession at its limit

A 'tsunami' of work is drowning general practice: GPs speak out about a profession at its limit

Rocketing workloads created by huge backlogs of cases and continuing COVID-19 disruption...

Slight increase in GP workforce during past year, but number of partners continues to fall

Slight increase in GP workforce during past year, but number of partners continues to fall

The GP workforce grew by 0.4% in the year to March 2021, but the number of GP partners...

Viewpoint: Patients and GPs are unhappy with access to general practice, what's the solution?

Viewpoint: Patients and GPs are unhappy with access to general practice, what's the solution?

Practices are deluged with work, yet many people still think they are ‘closed’. The...

Start date for COVID-19 booster campaign unclear, vaccines minister admits

Start date for COVID-19 booster campaign unclear, vaccines minister admits

A UK COVID-19 booster campaign could start from September - but could also remain...

BMA demands 'systemic change' after LMC report exposes racism in primary care

BMA demands 'systemic change' after LMC report exposes racism in primary care

Most black, Asian and minority ethnic primary care staff have experienced racism...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...